Award

Computational and biophysical approaches to disordered proteins

Rohit Pappu receives the 2025 DeLano Award for Computational Biosciences
Jay Thakkar
By Jay Thakkar
Nov. 14, 2024

When Rohit Pappu was a postdoctoral fellow at Johns Hopkins University working on protein folding, he had a conversation with Keith Dunker, a pioneer in the field of intrinsically disordered proteins, or IDPs. Dunker then shared a paper with him.

“I read that through the night,” Pappu said.

Rohit Pappu
Rohit Pappu

He realized that there might be a different way to think about IDPs — not just from a sequence analysis perspective, but also from a biophysical point of view.

After he set up his own lab at Washington University in St. Louis, Pappu started working on IDPs by combining atomistic and coarse-grained simulations with polymer physics principles to develop models that quantitatively describe their sequence–ensemble relationships.

The work in his lab has led to development of computational engines such as CAMPARI, LaSSI and CIDER. These are used to generate insights regarding the conformational ensembles, (CAMPARI), phase behaviors (LaSSI) and compositional biases as well as non-random sequence features of IDPs (CIDER). Insights and results from biophysical and informatics computations enable quantitative predictions that are testable using experiments, making these tools useful for the IDP and phase separation community and for noncomputational scientists.

Over the past two decades, Pappu’s work has been at the cornerstone of understanding function and phase behaviors of IDPs, and he will receive the American Society for Biochemistry and Molecular Biology’s 2025 DeLano Award for Computational Biosciences. Tanja Mittag and Alex Holehouse nominated Pappu for the award.

“The generality of conclusions borne from LaSSI simulations is a testament to the creativity of Prof. Pappu’s research program,” Mittag and Holehouse wrote in their nomination letter. “(T)he conceptual and computational ecosystem Prof. Pappu has developed over the course of his career has had a profound impact on the field of IDPs and biological phase separation.”

Decoding phases

Cells consist of compartments with distinct functions. However, some compartments lack a membrane, and they form reversibly via phase separation. Phase separation, which is driven by the poor solubility of macromolecules and the associations afforded by multivalent interactions, enables specific molecules to concentrate into specific localities within a cell. The bodies that form as the result of phase separation are known as biomolecular condensates.

In his studies, Rohit Pappu tries to predict and model the phase behaviors of biomolecules that include IDPs, nucleic acids and proteins that feature disordered regions and folded domains. This research also focuses on understanding the driving forces behind the formation of condensates. The foundational studies of what determines how condensates form have a direct impact on understanding how condensates contribute to neurodegenerative diseases and cancers.

Pappu’s computational approaches provide a platform for understanding how physical chemistry principles contribute to cellular localization and the makeup of condensates. These approaches, combined with experiments, help us better understand the microenvironments and players involved in creating molecular condensates.

Rohit Pappu will give a talk titled “Phase separation in cells: Insights from biophysical computations” at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Jay Thakkar
Jay Thakkar

Jay Thakkar is a researcher, who specializes in computer-aided drug design and discovery. He earned a bachelor's degree in chemical engineering from the Dwarkadas J. Sanghvi College of Engineering in Mumbai, India, and a master's degree in chemistry from the Stevens Institute of Technology in Hoboken, New Jersey, where he studied drug discovery. His hobbies include reading, driving on open roads and walking in the park.
 

Related articles

ASBMB names 2024 fellows
Marissa Locke Rottinghaus
First class
Judith S. Bond & Edward Eisenstein
Water is the 2024 molecule of the year
Marissa Locke Rottinghaus

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Join the pioneers of ferroptosis at cell death conference
In-person Conference

Join the pioneers of ferroptosis at cell death conference

Nov. 13, 2024

Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.

Helping underrepresented scientists feel seen
Award

Helping underrepresented scientists feel seen

Nov. 12, 2024

Benjamin Garcia will receive the ASBMB Ruth Kirschstein Diversity in Science Award at the ASBMB Annual meeting, April 12–15 in Chicago.

Honors for Emr, Sundquist, Ohm and Szoo
Member News

Honors for Emr, Sundquist, Ohm and Szoo

Nov. 11, 2024

Scott Emr and Wesley Sundquist won the 2024 Louisa Gross Horwitz Prize. Adam Ohm and Madeline Szoo have been awarded scholarships by the Fellowship Board of Tau Beta Pi.

In memoriam: Bengt Samuelsson
In Memoriam

In memoriam: Bengt Samuelsson

Nov. 11, 2024

He was a Nobel laureate, a professor at the Karolinska Institute, a lipid biochemist and an ASBMB member for almost 50 years.

A scientist's journey through disability, grad school, and beyond
Research Spotlight

A scientist's journey through disability, grad school, and beyond

Nov. 7, 2024

By the end of high school, Crystal Mendoza already had lab experience and was well on her way to a college degree and a promising future. All the bumps in her road lay ahead.

Brain-on-a-chip tech powers neuroscience research
Profile

Brain-on-a-chip tech powers neuroscience research

Nov. 4, 2024

MOSAIC scholar Brian O'Grady has engineered a biomimetic model of the brain’s blood vessels to help tackle glioblastoma.